Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06532643
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-30
Brief Title:
Safety and Efficacy of Anti-CD20CD30 CAR-T Cells in Subjects with RelapsedRefractory Lymphoma
Sponsor:
Organization:
None